Every year on 10 October many organisations, including the World Health Organisation (WHO), recognise World Mental Health Day. The objective is to raise awareness of mental health issues around the world and mobilize efforts in support of mental health. This year’s theme, set by the World Federation for Mental Health, is suicide prevention. This is an excellent time to turn our attention to latest Cochrane evidence and work.

The Mental Health and Neuroscience Network's  aim  is to coordinate work multiple Cochrane Review Groups. These Review Groups  facilitate the identification of reports of clinical trials and carry out systematic reviews of available evidence. These are published on the Cochrane Library, and updated periodically as new evidence is identified. This ensures that Cochrane Reviews are relevant, useful, usable, and used.

Cochrane Common Mental Disorders Group is a Review Group that  works with authors from around the world to produce and disseminate systematic reviews of healthcare interventions for treating and preventing a range of mental health problems. Some of the conditions they cover include depression, anxiety, eating disorders, somatoform disorders and suicide.

Related resources:

• Suicide prevention: towards better evidence - In this Evidently Cochrane blog, Jessica Hendon, the Managing Editor of Cochrane Common Mental Disorders Group, highlights the group’s ongoing work to bring together the best evidence on suicide prevention and self-harm.
• Special Collection: Reflecting on comorbidity in mental health and neuroscience - a multidisciplinary resource for people who use neurological and mental health services and for clinicians and decision-makers involved in service provision around the world. This Special Collection is the first to bring together the latest Cochrane evidence for interventions in people who are living with a range of comorbid conditions affecting the brain, nerves, or mind. It aims to inform clinical practice by highlighting the current evidence for the management of comorbidity, and potential gaps in the evidence that could inform new clinical questions and trials in mental health and neuroscience.